betamethasone has been researched along with tacrolimus in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.00) | 18.2507 |
| 2000's | 18 (36.00) | 29.6817 |
| 2010's | 24 (48.00) | 24.3611 |
| 2020's | 6 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kobayashi, I; Matsumoto, S; Nakanishi, M; Okano, M; Sakiyama, Y | 1 |
| Erkko, P; Granlund, H; Lauerma, AI; Reitamo, S; Remitz, A | 1 |
| Amaya, T; Goto, T; Higashi, Y; Ohkubo, Y; Sakuma, S; Sasakawa, T; Sato, N; Sengoku, T | 1 |
| Fujii, Y; Mutoh, S; Ohkubo, Y; Sakuma, S; Takeuchi, H; Tanaka, K | 1 |
| Chung, J; Kalthoff, FS; Musser, P; Stuetz, A | 1 |
| Fukagawa, S; Furue, M; Koga, T; Nakahara, T; Uchi, H | 1 |
| Gregoriou, S; Ioannides, D; Kalogeromitros, D; Katsambas, A; Rigopoulos, D | 1 |
| Goto, H; Hokama, H; Ishikawa, T; Katagiri, Y; Usui, M | 1 |
| Inoue, T; Katoh, N; Kishimoto, S | 1 |
| Altmeyer, P; Bräutigam, M; Brockmeyer, NH; Gambichler, T; Hyun, J; Kreuter, A; Sommer, A | 1 |
| Arimura, A; Deguchi, M; Haruna, T; Iduhara, M; Takahashi, H; Takaki, S; Yamamoto, M; Yasui, K | 1 |
| Ebert, AK; Rösch, WH; Vogt, T | 1 |
| Assad, GB; Buggiani, G; De Giorgi, V; Delescluse, J; Hercogova, J; Lotti, T; Troiano, M | 1 |
| Beiraghdar, F; Moharamzad, Y; Naghizadeh, MM; Panahi, Y | 1 |
| Andersson, C; Deleuran, B; Deleuran, M; Hvid, M; Jensen, HK; Kemp, K; Vestergaard, C | 1 |
| Bräutigam, M; Fölster-Holst, R; Jensen, JM; Neumann, C; Pfeiffer, S; Proksch, E; Schwarz, T; Weichenthal, M; Witt, M | 1 |
| Kabashima, K; Sakabe, JI; Sugita, K; Tokura, Y | 1 |
| Benedix, F; Geyer, A; Lichte, V; Metzler, G; Röcken, M; Strölin, A | 1 |
| Baron, JM; Heise, R; Merk, HF; Ott, H; Skazik, C | 1 |
| Cholongitas, E; Ioannidou, D; Kokolakis, GP; Krüger-Krasagakis, S | 1 |
| Agner, T; Hellegren, LI; Høgh, JK; Jemec, GB; Jungersted, JM | 1 |
| Bongiovanni, S; Bräutigam, M; Fölster-Holst, R; Jensen, JM; Kehren, J; Letzkus, M; Proksch, E; Scherer, A; Schwarz, T; Staedtler, F; Wanke, C; Weichenthal, M; Zuehlsdorf, M | 1 |
| Kamo, A; Negi, O; Ogawa, H; Suga, Y; Takamori, K; Taneda, K; Tengara, S; Tominaga, M | 1 |
| Annessi, G; Boccaletti, V; Cortelazzi, C; Di Nuzzo, S; Fabrizi, G; Fantini, C; Feliciani, C; Pagliarello, C; Zampetti, A | 1 |
| Joko, T; Ogata, M; Ohashi, Y; Shiraishi, A | 1 |
| Stein Gold, LF | 1 |
| Ikeda, R; Matsui, K; Tamai, S | 1 |
| Ebihara, N; Fujishima, H; Fukushima, A; Miyazaki, D; Nakagawa, Y; Namba, K; Ohashi, Y; Okamoto, S; Shoji, J; Takamura, E; Uchio, E | 1 |
| Bissonnette, R; Dickstein, D; Estrada, YD; Guttman-Yassky, E; Labuda, T; Malik, K; Oliva, M; Peng, X; Suarez-Farinas, M; Suprun, M; Todd, D; Ungar, B; Xu, H | 1 |
| Fukunaga, M; Hirai, T; Ikeda, K; Morimoto, S; Nakajima, S; Sekigawa, I; Tamura, N; Tanji, K; Tomita, S; Uomori, K | 1 |
| Nakamura, M; Saito, R; Sawada, Y | 1 |
| Jere, A; Singh, VK; Subramanian, I | 1 |
| Ezzatt, OM; Helmy, IM | 1 |
| Chen, H; Hong, J; Lan, L; Li, L; Liang, Y; Pan, N; Xie, Z | 1 |
| Al-Shenawy, HA; Elgendy, HY; Hassan, GF; Ibrahim, ZA | 1 |
| Baraldi, C; Barruscotti, S; Chessa, MA; Gurioli, C; Leuzzi, M; Neri, I; Savoia, F; Sechi, A; Virdi, A | 1 |
| Hong, J; Lan, L; Li, L; Liang, Y; Xiao, H; Xie, Z | 1 |
| Chen, K; Gao, XH; Gu, H; Li, H; Qiu, L; Sun, Y; Wang, H; Wu, Y; Zhang, J; Zhang, Y | 1 |
| Polcz, M; Wong, D; Yeh, R | 1 |
| Lim, HW; Silpa-Archa, N; Wongpraparut, C | 1 |
| Carley, SK; Kraus, CN; Lee, KH; Mesinkovska, NA | 1 |
| Asensio Llorente, M; Ezzeddine Ezzeddine, M; Gander, R; Leganés Villanueva, C; López Paredes, M; Royo Gomes, G | 1 |
| Ebihara, N; Fujishima, H; Fukushima, A; Inoue, Y; Miyazaki, D; Namba, K; Ohashi, Y; Okamoto, S; Shimizu, D; Shoji, J; Takamura, E; Uchio, E | 1 |
| Aketa, N; Hayashi, S; Ogawa, Y; Shimizu, E; Tsubota, K; Uchino, M; Yazu, H | 1 |
| Deng, X; Hou, F; Jiang, H; Jiang, L; Liang, Y; Qiu, X; Sun, Y; Xu, H; Xu, Y; Ye, L; Yuan, P; Zhang, Y | 1 |
| Forman, J; Gether, L; Hartmann, B; Holst, JJ; Jakasa, I; Kezic, S; Knop, FK; Pedersen, AJ; Røpke, MA; Skov, L; Skov-Jeppesen, K; Storgaard, H; Sørensen, OE; Thyssen, JP; van Hall, G | 1 |
5 review(s) available for betamethasone and tacrolimus
| Article | Year |
|---|---|
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Topics: Administration, Cutaneous; Anthralin; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Nicotinic Acids; Patient Compliance; Pharmaceutical Vehicles; Practice Guidelines as Topic; Psoriasis; Quality of Life; Severity of Illness Index; Tacrolimus; Treatment Outcome; Vitamin D | 2016 |
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature.
Topics: Adult; Antiviral Agents; Betamethasone; Colitis; Colon, Sigmoid; Cytomegalovirus; Cytomegalovirus Infections; Enteritis; Female; Ganciclovir; Gastrointestinal Hemorrhage; Humans; Immunocompromised Host; Immunosuppressive Agents; Intestinal Perforation; Lupus Nephritis; Prednisolone; Tacrolimus | 2017 |
Erosive pustular dermatosis of the scalp - an Australian perspective: Insights to aid clinical practice.
Topics: Algorithms; Anti-Inflammatory Agents; Australia; Betamethasone; Calcineurin Inhibitors; Curettage; Dermoscopy; Diagnosis, Differential; Glucocorticoids; Humans; Incidence; Mometasone Furoate; Recurrence; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Tacrolimus | 2019 |
Treatment of erosive pustular dermatosis: a systematic review of the literature.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Infective Agents; Betamethasone; Calcineurin Inhibitors; Clobetasol; Dapsone; Dexamethasone; Glucocorticoids; Humans; Leg Dermatoses; Methylprednisolone; Photochemotherapy; Scalp Dermatoses; Tacrolimus | 2020 |
Efficacy of topical administration for oral lichen planus: A network meta-analysis.
Topics: Administration, Topical; Betamethasone; Clobetasol; Humans; Lichen Planus, Oral; Network Meta-Analysis; Tacrolimus; Treatment Outcome | 2022 |
15 trial(s) available for betamethasone and tacrolimus
| Article | Year |
|---|---|
Tacrolimus ointment improves psoriasis in a microplaque assay.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Psoriasis; Skin Tests; Statistics, Nonparametric; Tacrolimus | 1999 |
Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Betamethasone; Chi-Square Distribution; Chronic Disease; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emollients; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Risk Assessment; Tacrolimus; Treatment Outcome | 2004 |
Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcineurin Inhibitors; Dermatitis, Seborrheic; Dermatologic Agents; Erythema; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pruritus; Recurrence; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2004 |
1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcineurin Inhibitors; Calcitriol; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Peptidylprolyl Isomerase; Psoriasis; Severity of Illness Index; Tacrolimus; Treatment Outcome | 2006 |
Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chemical Warfare Agents; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Mustard Gas; Ointments; Pruritus; Severity of Illness Index; Single-Blind Method; Tacrolimus; Treatment Outcome | 2009 |
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Atopic; Dermatologic Agents; Epidermis; Humans; Microscopy, Electron, Transmission; Skin Absorption; Tacrolimus; Water Loss, Insensible | 2009 |
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Betamethasone; Ceramides; Cholesterol; Chromatography, High Pressure Liquid; Denmark; Dermatitis, Irritant; Electric Capacitance; Emollients; Erythema; Female; Forearm; Humans; Immunosuppressive Agents; Male; Middle Aged; Skin; Skin Irritancy Tests; Sodium Dodecyl Sulfate; Tacrolimus; Time Factors; Water Loss, Insensible; Young Adult | 2011 |
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
Topics: Adult; Betamethasone; Calcineurin; Calcineurin Inhibitors; Cell Membrane Permeability; Dermatitis, Atopic; Double-Blind Method; Female; Filaggrin Proteins; Gene Expression Profiling; Glucocorticoids; Humans; Male; Oligonucleotide Array Sequence Analysis; Proteins; Skin; Tacrolimus; Treatment Outcome; Young Adult | 2012 |
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Biomarkers; Cell Differentiation; Clobetasol; Cytokines; Dermatitis, Atopic; Female; Humans; Hyperplasia; Male; Middle Aged; Placebo Effect; Psoriasis; Skin; Tacrolimus; Young Adult | 2017 |
Topical pimecrolimus versus betamethasone for oral lichen planus: a randomized clinical trial.
Topics: AC133 Antigen; Administration, Topical; Adult; Betamethasone; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Middle Aged; Tacrolimus; Treatment Outcome | 2019 |
The effectiveness of combination therapy with 308-nm excimer laser in vitiligo in Han Chinese People.
Topics: Adult; Asian People; Betamethasone; Calcineurin Inhibitors; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Lasers, Excimer; Low-Level Light Therapy; Male; Middle Aged; Skin Pigmentation; Tacrolimus; Vitiligo | 2019 |
Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo.
Topics: Acupuncture Therapy; Administration, Cutaneous; Adolescent; Adult; Betamethasone; Calcitriol; Child; Combined Modality Therapy; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Needles; Skin; Tacrolimus; Treatment Outcome; Vitiligo; Young Adult | 2019 |
The effectiveness of topical therapy combined with 308-nm excimer laser on vitiligo compared to excimer laser monotherapy in pediatric patients.
Topics: Administration, Topical; Betamethasone; Child; Combined Modality Therapy; Dermatologic Agents; Humans; Lasers, Excimer; Prospective Studies; Skin Pigmentation; Tacrolimus; Treatment Outcome; Vitiligo | 2019 |
A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0·1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo.
Topics: Administration, Cutaneous; Adult; Betamethasone; Combined Modality Therapy; Face; Female; Humans; Injections, Intramuscular; Lasers, Excimer; Low-Level Light Therapy; Male; Middle Aged; Neck; Skin Pigmentation; Tacrolimus; Treatment Outcome; Vitiligo | 2019 |
Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis-A randomized controlled study.
Topics: Adrenal Cortex Hormones; Adult; Betamethasone; Dermatitis, Atopic; Dermatologic Agents; Diabetes Mellitus, Type 2; Double-Blind Method; Glucocorticoids; Homeostasis; Humans; Insulin Resistance; Tacrolimus; Treatment Outcome | 2023 |
30 other study(ies) available for betamethasone and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy.
Topics: Autoimmune Diseases; Betamethasone; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Genetic Linkage; Humans; Immunosuppressive Agents; Infant; Intestinal Diseases; Male; Sex Chromosome Aberrations; Tacrolimus; X Chromosome | 1995 |
Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids).
Topics: Betamethasone; CD28 Antigens; CD3 Complex; CD4 Antigens; Cell Separation; Cells, Cultured; Cytokines; Depression, Chemical; Dermatitis, Atopic; Enzyme-Linked Immunosorbent Assay; Humans; Immunosuppressive Agents; Indicators and Reagents; Methylprednisolone; Monocytes; Steroids; Tacrolimus | 2001 |
Effects of FK506 (tacrolimus hydrate) on chronic oxazolone-induced dermatitis in rats.
Topics: Animals; Betamethasone; Calcitriol; Dermatitis, Allergic Contact; Ear; Enzyme-Linked Immunosorbent Assay; Glucocorticoids; Immunosuppressive Agents; Interferon-gamma; Interleukin-4; Oxazolone; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin; Tacrolimus | 2002 |
Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids.
Topics: Apoptosis; Betamethasone; Calcineurin Inhibitors; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dexamethasone; Flow Cytometry; Glucocorticoids; Humans; Immunosuppressive Agents; In Situ Nick-End Labeling; Lipopolysaccharides; Lymphocyte Activation; T-Lymphocytes; Tacrolimus | 2003 |
Effects of intravitreal injection of tacrolimus (FK506) in experimental uveitis.
Topics: Animals; Betamethasone; Disease Models, Animal; Electroretinography; Glucocorticoids; Immunosuppressive Agents; Injections; Male; Neuroprotective Agents; Rabbits; Serum Albumin, Bovine; Tacrolimus; Uveitis; Vitreous Body | 2005 |
Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells.
Topics: Administration, Topical; Animals; Betamethasone; Cell Degranulation; Emollients; Glucocorticoids; Hypersensitivity, Immediate; Immunosuppressive Agents; Male; Mast Cells; Mice; Mice, Inbred BALB C; Ovalbumin; Petrolatum; Tacrolimus | 2006 |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
Topics: Adrenal Cortex Hormones; Allergens; Animals; Betamethasone; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Immunoglobulin E; Immunosuppressive Agents; Interferon-gamma; Interleukin-13; Interleukin-5; Lymph Nodes; Mice; Reproducibility of Results; Skin; Tacrolimus | 2007 |
[Topical therapy of balanitis xerotica obliterans in childhood. Long-term clinical results and an overview].
Topics: Administration, Topical; Adolescent; Balanitis; Betamethasone; Child; Child, Preschool; Circumcision, Male; Combined Modality Therapy; Follow-Up Studies; Humans; Male; Penis; Recurrence; Tacrolimus; Urethral Stricture | 2007 |
Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Phenylalanine; Photochemotherapy; Severity of Illness Index; Tacrolimus; Treatment Outcome; Ultraviolet Therapy; Vitiligo; Young Adult | 2008 |
Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Atopic; Diagnosis, Computer-Assisted; Disease Models, Animal; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Haptens; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Skin; Software; Tacrolimus | 2009 |
Possible involvement of T lymphocytes in the pathogenesis of Nagashima-type keratosis palmoplantaris.
Topics: Betamethasone; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Keratoderma, Palmoplantar; T-Lymphocyte Subsets; Tacrolimus | 2009 |
Response of ulcerated necrobiosis lipoidica to clofazimine.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Clofazimine; Female; Humans; Immunosuppressive Agents; Necrobiosis Lipoidica; Stockings, Compression; Tacrolimus | 2009 |
Tacrolimus modulates dendritic cell activation in the sensitization phase of allergic contact dermatitis.
Topics: Acrolein; Antigen-Presenting Cells; Betamethasone; Cell Line, Tumor; Dendritic Cells; Dermatitis, Allergic Contact; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-8; Monocytes; Polymerase Chain Reaction; Tacrolimus; Trinitrobenzenesulfonic Acid | 2010 |
Guttate psoriasis occurring on varicella lesions.
Topics: Betamethasone; Chickenpox; Child, Preschool; Erythromycin; Humans; Male; Psoriasis; Tacrolimus; Treatment Outcome | 2010 |
Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Behavior, Animal; Betamethasone; Dermatitis, Atopic; Dermatophagoides farinae; Drug Therapy, Combination; Epidermis; Immunosuppressive Agents; Male; Mice; Mice, Inbred Strains; Nerve Endings; Ointments; Pruritus; Semaphorin-3A; Specific Pathogen-Free Organisms; Tacrolimus | 2012 |
Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Immunosuppressive Agents; Ointments; Scalp Dermatoses; Tacrolimus | 2015 |
Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine.
Topics: Acyclovir; Administration, Topical; Betamethasone; Child; Cyclosporine; Drug Substitution; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratitis; Male; Recurrence; Tacrolimus; Treatment Outcome | 2016 |
Betamethasone, but Not Tacrolimus, Suppresses the Development of Th2 Cells Mediated by Langerhans Cell-Like Dendritic Cells.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Betamethasone; Bone Marrow Cells; Dendritic Cells; Immunosuppressive Agents; Langerhans Cells; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Peptides; Receptors, Antigen, T-Cell; Tacrolimus; Th2 Cells | 2016 |
Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases.
Topics: Administration, Oral; Administration, Topical; Adolescent; Betamethasone; Calcineurin Inhibitors; Child; Cohort Studies; Conjunctivitis, Allergic; Corneal Ulcer; Drug Therapy, Combination; Epithelium, Corneal; Female; Fluorometholone; Glucocorticoids; Humans; Male; Ophthalmic Solutions; Retrospective Studies; Tacrolimus; Young Adult | 2017 |
Two cases of eczematous drug eruption caused by oral tacrolimus administration.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Betamethasone; Drug Eruptions; Female; Humans; Immunosuppressive Agents; Middle Aged; Tacrolimus | 2017 |
Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach.
Topics: Administration, Topical; Betamethasone; Dermatitis, Atopic; Dermatologic Agents; Humans; Systems Biology; Tacrolimus; Transcriptome | 2018 |
Zoon's plasma cell balanitis: clinical and dermoscopic features in pediatric patients.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Balanitis; Betamethasone; Biopsy; Dermoscopy; Fusidic Acid; Glucocorticoids; Humans; Infant; Male; Plasma Cells; Tacrolimus | 2018 |
Excimer laser in vitiligo: where there is light, there is hope.
Topics: Betamethasone; Humans; Hypopigmentation; Lasers, Excimer; Tacrolimus; Vitiligo | 2019 |
Treatment of balanitis xerotica obliterans in pediatric patients.
Topics: Adolescent; Balanitis Xerotica Obliterans; Betamethasone; Child; Child, Preschool; Circumcision, Male; Dexamethasone; Follow-Up Studies; Glucocorticoids; Humans; Male; Penis; Phimosis; Recurrence; Reoperation; Retrospective Studies; Tacrolimus | 2020 |
Reduced steroid-induced intraocular pressure elevation in tacrolimus-treated refractory allergic ocular diseases.
Topics: Adolescent; Betamethasone; Glaucoma; Humans; Intraocular Pressure; Ocular Hypertension; Tacrolimus; Tonometry, Ocular | 2020 |
The Overlap Syndrome: A Case Report of Chronic Graft-Versus-Host Disease After the Development of a Pseudomembrane.
Topics: Acute Disease; Betamethasone; Chronic Disease; Conjunctival Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Intestinal Diseases; Leukemia, Myeloid, Acute; Male; Middle Aged; Ophthalmologic Surgical Procedures; Skin Diseases; Tacrolimus | 2021 |